/Viatris%20Inc%20logo%20on%20building-by%20SSKH-Pictures%20via%20Shutterstock.jpg)
Based in Canonsburg, Pennsylvania, Viatris Inc. (VTRS) is a global healthcare company dedicated to empowering people worldwide to live healthier lives at every stage of life. Valued at $14 billion by market cap, the company focuses on providing access to a broad range of trusted, quality medicines. Viatris leverages its strong portfolio of pharmaceutical products, including generics, branded medicines, complex generics, and biosimilars. The company's commitment to sustainability and innovation drives its operations across more than 165 countries and territories. Viatris is scheduled to announce its fiscal Q2 earnings results before the market opens on Thursday, Aug. 8.
Ahead of the event, analysts expect VTRS to report a profit of $0.68 per share, down 9.3% from $0.75 per share in the year-ago quarter. In the last four quarters, the company has surpassed Wall Street’s bottom-line estimates in two and missed on other occasions.